(Q41603358)

4 October 2017

1 reference

title

Tactics for type II diabetes (English)

1 reference

4 October 2017

0 references

Riddle MC

1

1 reference

4 October 2017

publication date

1 September 1997

1 reference

Endocrinology and Metabolism Clinics of North America

4 October 2017

published in

1 reference

4 October 2017

volume

26

1 reference

4 October 2017

issue

3

1 reference

4 October 2017

page(s)

659-677

1 reference

Different aetiologies of type 2 (non-insulin-dependent) diabetes mellitus in obese and non-obese subjects

4 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970273-5

7 January 2021

Diabetes in identical twins. A study of 200 pairs

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970273-5

7 January 2021

A comparison of acarbose versus metformin as an adjuvant therapy in sulfonylurea-treated NIDDM patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970273-5

7 January 2021

Comparative efficacy of a once-daily controlled-release formulation of glipizide and immediate-release glipizide in patients with NIDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970273-5

7 January 2021

Declining Incidence of Nephropathy in Insulin-Dependent Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970273-5

7 January 2021

Rapid HbA1c testing in a community setting

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970273-5

7 January 2021

The efficacy of acarbose in the treatment of patients with non-insulin-dependent diabetes mellitus. A multicenter controlled clinical trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970273-5

7 January 2021

Frequency and determinants of screening for diabetes in the U.S.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970273-5

7 January 2021

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970273-5

7 January 2021

Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970273-5

7 January 2021

Prevention of type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise. The 6-year Malmö feasibility study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970273-5

7 January 2021

Familial hyperglycemia due to mutations in glucokinase. Definition of a subtype of diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970273-5

7 January 2021

A dose-response study of glimepiride in patients with NIDDM who have previously received sulfonylurea agents. The Glimepiride Protocol #201 Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970273-5

7 January 2021

Plasma Insulin and Glucose Profiles in Normal, Obese, and Diabetic Persons

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970273-5

7 January 2021

Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970273-5

7 January 2021

Undiagnosed NIDDM: clinical and public health issues.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970273-5

7 January 2021

Effect of intensive treatment of diabetes of the risk of death or renal failure in NIDDM and IDDM

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970273-5

7 January 2021

Intensive conventional insulin therapy for type II diabetes. Metabolic effects during a 6-mo outpatient trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970273-5

7 January 2021

Therapeutic comparison of metformin and sulfonylurea, alone and in various combinations. A double-blind controlled study.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970273-5

7 January 2021

Forum Three: Changes in the U.S. health care system that would facilitate improved care for non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970273-5

7 January 2021

Islet function and insulin sensitivity in the non-diabetic offspring of conjugal type 2 diabetic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970273-5

7 January 2021

Banting Lecture. Insulin action, diabetogenes, and the cause of type II diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970273-5

7 January 2021

Genetics of non-insulin-dependent (type-II) diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970273-5

7 January 2021

Hyperglycemia and microvascular and macrovascular disease in diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970273-5

7 January 2021

Relation of glycemic control to diabetic microvascular complications in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970273-5

7 January 2021

Fasting plasma glucose as a screening test for diabetes and its relationship with cardiovascular risk factors in Hong Kong Chinese.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970273-5

7 January 2021

Epidemiology of late diabetic complications. A basis for the development and evaluation of preventive programs

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970273-5

7 January 2021

Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970273-5

7 January 2021

Comparison of tests for glycated haemoglobin and fasting and two hour plasma glucose concentrations as diagnostic methods for diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970273-5

7 January 2021

Which test for diagnosing diabetes?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970273-5

7 January 2021

A systematic approach to diabetes management in the post-DCCT era.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970273-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970273-5

1 reference

7 January 2021

Prepregnancy weight and antepartum insulin secretion predict glucose tolerance five years after gestational diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970273-5

7 January 2021

Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970273-5

7 January 2021

Fasting plasma glucose in screening for NIDDM in the U.S. and Israel

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970273-5

7 January 2021

A two-step strategy for identification of high-risk subjects for a clinical trial of prevention of NIDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970273-5

7 January 2021

Inferences and implications. Do results from the Diabetes Control and Complications Trial apply in NIDDM?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970273-5

7 January 2021

The pathophysiology of diabetic complications: how much does the glucose hypothesis explain?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970273-5

7 January 2021

Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970273-5

7 January 2021

Diabetes Mellitus After GDM

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970273-5

7 January 2021

GHb is a better predictor of cardiovascular disease than fasting or postchallenge plasma glucose in women without diabetes. The Rancho Bernardo Study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970273-5

7 January 2021

A clinical approach for the diagnosis of diabetes mellitus: an analysis using glycosylated hemoglobin levels. Meta-analysis Research Group on the Diagnosis of Diabetes Using Glycated Hemoglobin Levels.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970273-5

7 January 2021

Seminars in Medicine of the Beth Israel Hospital, Boston. Non-insulin-dependent diabetes mellitus - a genetically programmed failure of the beta cell to compensate for insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970273-5

7 January 2021

Diabetes in a managed care system.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970273-5

7 January 2021

Effect of acarbose on carbohydrate and lipid metabolism in NIDDM patients poorly controlled by sulfonylureas.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970273-5

7 January 2021

Efficacy of bedtime NPH insulin with daytime sulfonylurea for subpopulation of type II diabetic subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970273-5

7 January 2021

Combined therapy for obese type 2 diabetes: suppertime mixed insulin with daytime sulfonylurea

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970273-5

7 January 2021

Combined therapy with a sulfonylurea plus evening insulin: safe, reliable, and becoming routine

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970273-5

7 January 2021

Glimepiride, a new once-daily sulfonylurea. A double-blind placebo-controlled study of NIDDM patients. Glimepiride Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970273-5

7 January 2021

Health care expenditures for people with diabetes mellitus, 1992.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970273-5

7 January 2021

Diabetic complications. The importance of glucose control

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970273-5

7 January 2021

Metabolic effects of metformin in non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970273-5

7 January 2021

Lifestyle changes may reverse development of the insulin resistance syndrome. The Oslo Diet and Exercise Study: a randomized trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970273-5

7 January 2021

U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. U.K. Prospective Diabetes Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970273-5

7 January 2021

Insulin secretion, insulin action, and hepatic glucose production in identical twins discordant for non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970273-5

7 January 2021

Differences in 4-year health outcomes for elderly and poor, chronically ill patients treated in HMO and fee-for-service systems. Results from the Medical Outcomes Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970273-5

7 January 2021

Does increased access to primary care reduce hospital readmissions? Veterans Affairs Cooperative Study Group on Primary Care and Hospital Readmission

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970273-5

7 January 2021

10.1016/S0889-8529(05)70273-5

Identifiers

DOI

1 reference

release_756rs52dvbacpd6k57siue7rri

4 October 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/756rs52dvbacpd6k57siue7rri

24 November 2022

mapped directly with Wikidata item

1 reference